Artificial nutritional support - What are the options?

Hospital Pharmacist

Volumn 7, Issue 6, 2000, Pages 146-154

  Murphy, A ^a   Scott, A ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARGININE; CALCIUM PHOSPHATE; GLUTAMINE; LIPID EMULSION; NUCLEOTIDE; POLYUNSATURATED FATTY ACID; RANITIDINE; TRACE ELEMENT; TRIACYLGLYCEROL; VITAMIN;

ARTIFICIAL FEEDING; CLINICAL TRIAL; DRUG STABILITY; FOOD CONTAMINATION; HOME CARE; HUMAN; LIVER DISEASE; META ANALYSIS; PARENTERAL NUTRITION; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SEPSIS;

EID: 0033824809     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Growth and development of an infant receiving all nutrients exclusively by vein
2. Benefits of supplementary tube feeding after fractured neck of femur; a randomised controlled trial
3. Dietary supplementation in elderly patients with fractured neck of femur
4. Existence, causes and consequences of disease-related malnutrition in the hospital and community and clinical and financial benefits of nutritional intervention
5. Incidence and recognition of malnutrition in hospital
6. Infusion Protocol improves delivery of enteral tube feeding in the critical care unit
7. Overnight nasogastric tube feeding
8. Percutaneous endoscopic gastrostomy. Indications, timing and complications of the technique
9. Predicting basal metabolic rate, new standards and review of previous work
10. Artificial nutritional support
11. Enteral feeding related diarrhoea: Proposed causes and possible solutions
12. Probiotics and prebiotics: Can regulating the activities of intestinal bacteria benefit health?
13. Randomised clinical outcome study of critically ill patients given glutamine supplemented enteral nutrition
14. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma
15. Immune and metabolic effects of arginine in the surgical patient
16. The role of nucleotides in adult nutrition
17. Dietary polyunsaturated fatty acids and eicosanoids: Potential effects on the modulation of inflammatory and immune cells: An overview
18. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides and fish oil in intensive care unit patients: Results of a multi-centre, prospective randomised controlled trial
19. An immune-enhancing enteral diet reduces mortality and episodes of bacteremia in septic ICU patients
20. Jejunal efflux in short bowel syndrome
21. Total parenteral nutrition needs in different types of short bowel syndrome
22. Nutrition support in clinical practice. Review of published data and recommendations for future research directions
23. Prospective randomised controlled trials. When the gold in the gold standard isn't pure
24. Total parenteral nutrition in the critically ill patient. A meta analysis
25. Perioperative TPN in surgical patients
26. Nutrition and metabolic support in the 21st century
27. An evidence-based evaluation of intradialytic parenteral nutrition
28. Response to intradialytic parenteral nutrition
29. Metabolic and monetary costs of avoidable parenteral nutrition use
30. High osmolality feedings do not increase the incidence of thrombophlebitis during peripheral intravenous nutrition
31. Fine-bore cannulas for peripheral intravenous nutrition: Polyurethane or silicone?
32. Ultrasonic investigation of the effects of topical glyceryl trinitrate on peripheral arm vein diameter: Implications for intravenous nutrition
33. Influence of fine bore catheter length on the infusion thrombophlebitis in peripheral intravenous nutrition: A randomised controlled trial
34. A comparative study of polyurethane and silicone cuffed catheters in long-term home parenteral nutrition patients
35. Peripherally inserted central catheters for parenteral nutrition: A comparison with centrally inserted catheters
36. Overfeeding macronutrients to critically ill adults: Metabolic complications
37. Hypocaloric support in the critically ill
38. Essential fatty acid deficiency in patients receiving home parenteral nutrition
39. Increased lipoprotein X causes hypedipidaemia during IV administration of 10 per cent fat emulsion in man
40. Comparison between two fat emulsions: Intralipid 30 per cent vs 10 per cent in critically ill patients
41. Parenteral infusion of long and medium chain triglycerides and reticuloendothelial function in man
42. Medium and long chain triacylglycerols in postoperative patients: Structured lipids versus a physical mixture
43. Total parenteral nutrition with glutamine dipeptide shortened hospital stays and improved immune status and nitrogen economy after major abdominal surgery
44. Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: A randomised, double blind, controlled study
45. The stability of intravenous fat emulsions in TPN admixtures
46. Physical stability of all-in-one admixtures: Factors affecting fat droplets
47. Physicochemical stability of two types of intravenous lipid emulsion as total nutrient admixtures
48. Peroxidation of lipid emulsions. A hazard for the premature infant receiving PN
49. Toxic hydroperoxides in intravenous lipid emulsions used in preterm infants
50. Generation of free radicals in lipid emulsions used in parenteral nutrition
51. Lipid peroxidation; its mechanism, management and significance
52. Protecting solutions of parenteral nutrition from peroxidation
53. Lipid peroxidation of intravenous lipid emulsions in TPN bags: The influence of tocopherols
54. Lipid peroxidation of intravenous lipid emulsions and all in one admixtures in TPN bags. The influence of trace elements
55. Hazards of precipitation associated with parenteral nutrition
56. Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution
57. Microvascular pulmonary emboli secondary to precipitated crystals in a patient receiving total parenteral nutrition: A case report and description of the high resolution CT findings
58. Calcium and phosphorus in neonatal nutrition solutions
59. Compatibility and stability of additives in parenteral nutrition admixtures
60. The dissolved oxygen content of PN admixtures prepared by different methods
61. Oxalogenesis in PN solution components
62. The destabilisation of parenteral feeding emulsions by heparin
63. Heparin in parenteral feeding: Effect of heparin and low molecular weight heparin on lipid emulsions and all-in-one admixtures
64. Incompatibility between fat emulsion and calcium plus heparin in parenteral nutrition of premature babies
65. An investigation into the physical stability of a neonatal nutrition formulation
66. Stability threatening interactions during simulated Y-site delivery of total parenteral nutrition (TPN) admixtures
67. Assessment of trace element compatibility in total parenteral nutrition infusions
68. Detection of particulate material in parenteral nutrition admixtures
69. Fundamentals of trace element precipitation using multi-element additives in parenteral nutrition (PN) admixtures
70. Long-term stability of cimetidine in total parenteral nutrition
71. Factors influencing the stability of ranitidine in TPN mixtures
72. Compatibility of medications with 3 in 1 parenteral nutrition admixtures
73. Response of severely malnourished patients to preoperative parenteral nutrition: A randomised trial of water and sodium restriction
74. Manganese toxicity in children receiving long-term parenteral nutrition
75. Hypermanganesemia in long term intravenous nutrition and chronic liver disease
76. Aluminium neurotoxicity in preterm infants receiving intravenous feeding solutions
77. The aluminium content of parenteral solutions: Current staus
78. Aluminium in parenteral solutions revisited - Again
79. Trace element contamination of parenteral nutrition. (1) Contribution of component solutions
80. Trace element contamination of parenteral nutrition. (2) Effect of storage duration and temperature
81. Wernicke encephalopathy and beriberi during total parenteral nutrition attributable to multivitamin infusion shortage
82. Metabolic acidosis and thiamine deficiency
83. Rapid development of severe copper deficiency in a patient with Crohn's disease receiving parenteral nutrition
84. Nutritional support in hepatic encephalopathy
85. Fulminant hepatic failure: Nutrition and fat clearance
86. Intravenous lipid dose and the incidence of bacteraemia and fungaemia in patients undergoing bone marrow transplant
87. Effect of a lipid emulsion (Intralipid) on polymorphonuclear leukocyte functions in the neonate
88. Neutrophil dysfunction the cellular mechanism of impaired immunity during total parenteral nutrition in infancy
89. Hazards of parenteral treatment: Do particles count?
90. Particle contamination in a ternary nutritional admixture
91. Safe practices for parenteral nutrition formulations
92. Problems with lines and the pharmacist's role
93. Severe liver complications associated with long-term parenteral nutrition are dependent on lipid parenteral input
94. Home parenteral nutrition 25 years later
95. Nutritional status assessment of patients on HPN: Antropometry, bioelectrical impedance, or clinical judgement
96. Quality of life in patients receiving home parenteral nutrition